EGI
EVH icon

EAM Global Investors’s Evolent Health EVH Stock Holding History

EAM Global Investors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-131,493
Closed -$4.72M – 199
2022
Q3 		$4.72M Buy
131,493
+15,484
+13% +$545K 1.26% 9
2022
Q2 		$3.56M Sell
116,009
-23,555
-17% -$686K 0.87% 22
2022
Q1 		$4.51M Sell
139,564
-2,964
-2% -$77.6K 0.83% 26
2021
Q4 		$3.94M Buy
142,528
+10,492
+8% +$301K 0.7% 22
2021
Q3 		$4.09M Buy
+132,036
New +$3.17M 0.97% 12

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

EAM Global Investors's EVH Position: Q4 2022 in Review

EAM Global Investors sold out of Evolent Health (EVH) in Q4 2022, closing a stake of 131,493 shares — an estimated $4.72M sold.

EAM Global Investors first reported a position in EVH in Q3 2021 and held it in 5 quarters. The position peaked at $4.72M in Q3 2022. 232 funds tracked by Wall St. Rank hold EVH as of Q4 2022.

  • EAM Global Investors reported no remaining Evolent Health position as of Q4 2022 after selling out during the quarter.
  • EAM Global Investors sold 131,493 Evolent Health shares in Q4 2022, an estimated $4.72M.
  • EAM Global Investors first reported a position in Evolent Health in Q3 2021 and held it in 5 quarters.
  • EAM Global Investors's Evolent Health position peaked at $4.72M in Q3 2022.
  • 232 funds tracked by Wall St. Rank held Evolent Health as of Q4 2022.

Based on EAM Global Investors's 13F filing for Q4 2022, filed 14 Feb 2023.